Toggle navigation
Home
Search
Services
Blog
Contact
About
DNA Ligase I in Bloom's Syndrome and Immunodeficiency
Petrini, John Hj
Dana-Farber Cancer Institute, Boston, MA, United States
Search 53 grants from John Petrini
Search grants from Dana-Farber Cancer Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Intraoperative Analytics and Enhanced Patient Outcomes
Research Infrastructure Development
Polyploidy in Phlox and its effects on diversity
Emperical Analyses of Competitive Bidding
CAREER: Randomization in Graph Optimization Problems
Recently added grants:
Role of the lncRNA BORG in Breast Cancer Metastatic Progression and Recurrence
SRC-3/PELP1 complexes drive stem-like phenotypes in luminal breast cancer
Cognitive impairment associated with androgen deprivation therapy for prostate cancer
Combinational targeting the feed forward epigenetic circuitry in mixed lineage leukemia
Correlative efficacy, biomarker, and mechanistic studies associated with a phase Ib/II clinical trial of treating mCRPC patients with enzalutamide and Venetoclax
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32AI008308-02
Application #
3030418
Study Section
Immunology, Virology, and Pathology Study Section (IVP)
Project Start
1991-09-01
Project End
Budget Start
1991-09-01
Budget End
1992-08-31
Support Year
2
Fiscal Year
1991
Total Cost
Indirect Cost
Institution
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Related projects
NIH 1991
F32 AI
DNA Ligase I in Bloom's Syndrome and Immunodeficiency
Petrini, John Hj / Dana-Farber Cancer Institute
NIH 1990
F32 AI
DNA Ligase I in Bloom's Syndrome and Immunodeficiency
Petrini, John Hj / Dana-Farber Cancer Institute
Comments
Be the first to comment on John Petrini's grant